Enanta Pharmaceuticals Inc (ENTA): ENTA sues PFE for patent infringement wr...

Reply Private New

Replies (4) Next 10 Prev Next

Send PM Follow Ignore

Followers	839
Posts	120487
Boards Moderated	18
Alias Born	09/05/2002

DewDiligence

Re: None

Tuesday, 06/21/2022 5:01:14 PM

Tuesday, June 21, 2022 5:01:14 PM

ENTA sues PFE for patent infringement wrt Paxlovid:

https://ir.enanta.com/news-releases/news-release-details/enanta-pharmaceuticals-files-patent-infringement-suit-against

Enanta Pharmaceuticals…announced today that it has filed suit in United States District Court for the District of Massachusetts against Pfizer, Inc. seeking damages for infringement of U.S. Patent No. 11,358,953 (the ’953 Patent) in the manufacture, use and sale of Pfizer’s COVID-19 antiviral, Paxlovid (nirmatrelvir tablets; ritonavir tablets). The United States Patent and Trademark Office awarded the patent to Enanta earlier this month based on Enanta’s July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists.

The legal complaint filed with the Court today is at:
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fenanta.gcs-web.com%2FEnantadocument6-21-22.pdf&esheet=52757602&newsitemid=20220621006054&lan=en-US&anchor=here&index=2&md5=f358054262ce7655dd507a75f02d8073

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”